Tilray (TLRY) Competitors $1.16 -0.08 (-6.45%) (As of 05:45 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends TLRY vs. CRON, USNA, MNMD, CDXC, BTMD, CGC, ACB, MDWD, FTLF, and SNYRShould you be buying Tilray stock or one of its competitors? The main competitors of Tilray include Cronos Group (CRON), USANA Health Sciences (USNA), Mind Medicine (MindMed) (MNMD), ChromaDex (CDXC), biote (BTMD), Canopy Growth (CGC), Aurora Cannabis (ACB), MediWound (MDWD), FitLife Brands (FTLF), and Synergy CHC Corp. (Uplisting) (SNYR). These companies are all part of the "medicinals & botanicals" industry. Tilray vs. Cronos Group USANA Health Sciences Mind Medicine (MindMed) ChromaDex biote Canopy Growth Aurora Cannabis MediWound FitLife Brands Synergy CHC Corp. (Uplisting) Cronos Group (NASDAQ:CRON) and Tilray (NASDAQ:TLRY) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, media sentiment, analyst recommendations, risk, institutional ownership, profitability, earnings and community ranking. Does the media favor CRON or TLRY? In the previous week, Tilray had 13 more articles in the media than Cronos Group. MarketBeat recorded 15 mentions for Tilray and 2 mentions for Cronos Group. Cronos Group's average media sentiment score of 1.59 beat Tilray's score of 0.49 indicating that Cronos Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cronos Group 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Tilray 2 Very Positive mention(s) 3 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Do insiders & institutionals have more ownership in CRON or TLRY? 8.7% of Cronos Group shares are owned by institutional investors. Comparatively, 9.4% of Tilray shares are owned by institutional investors. 6.9% of Cronos Group shares are owned by company insiders. Comparatively, 0.9% of Tilray shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Do analysts prefer CRON or TLRY? Cronos Group currently has a consensus price target of $3.00, indicating a potential upside of 51.13%. Tilray has a consensus price target of $2.63, indicating a potential upside of 110.84%. Given Tilray's stronger consensus rating and higher probable upside, analysts plainly believe Tilray is more favorable than Cronos Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cronos Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00Tilray 0 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.25 Is CRON or TLRY more profitable? Tilray has a net margin of -26.79% compared to Cronos Group's net margin of -42.65%. Tilray's return on equity of -2.00% beat Cronos Group's return on equity.Company Net Margins Return on Equity Return on Assets Cronos Group-42.65% -2.56% -2.47% Tilray -26.79%-2.00%-1.60% Which has more risk & volatility, CRON or TLRY? Cronos Group has a beta of 0.99, meaning that its share price is 1% less volatile than the S&P 500. Comparatively, Tilray has a beta of 2.08, meaning that its share price is 108% more volatile than the S&P 500. Which has higher valuation & earnings, CRON or TLRY? Cronos Group has higher earnings, but lower revenue than Tilray. Cronos Group is trading at a lower price-to-earnings ratio than Tilray, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCronos Group$111.23M6.82-$73.96M-$0.13-15.27Tilray$210.48M5.34-$244.98M-$0.27-4.61 Does the MarketBeat Community favor CRON or TLRY? Cronos Group received 17 more outperform votes than Tilray when rated by MarketBeat users. Likewise, 61.13% of users gave Cronos Group an outperform vote while only 59.21% of users gave Tilray an outperform vote. CompanyUnderperformOutperformCronos GroupOutperform Votes46461.13% Underperform Votes29538.87% TilrayOutperform Votes44759.21% Underperform Votes30840.79% SummaryTilray beats Cronos Group on 11 of the 18 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life-changing for those who are prepared. Why? Because altcoin prices are about to explode.>> Register for the Workshop Now Get Tilray News Delivered to You Automatically Sign up to receive the latest news and ratings for TLRY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TLRY vs. The Competition Export to ExcelMetricTilrayMedicinals & botanicals IndustryStaples SectorNASDAQ ExchangeMarket Cap$1.12B$397.95M$14.42B$9.28BDividend YieldN/AN/A2.69%4.06%P/E Ratio-4.6136.8822.8817.51Price / Sales5.346.082.75142.21Price / CashN/A10.6621.1437.95Price / Book0.301.995.924.94Net Income-$244.98M-$51.46M$577.44M$225.59M7 Day Performance-1.19%-0.56%-1.59%-1.07%1 Month Performance-5.68%-3.85%1.61%7.23%1 Year Performance-37.12%-3.44%5.86%22.97% Tilray Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TLRYTilray2.7747 of 5 stars$1.16-6.5%$2.63+126.3%-39.7%$1.05B$210.48M-4.302,650Analyst RevisionGap DownCRONCronos Group2.3543 of 5 stars$1.93+0.1%$3.00+55.3%+1.0%$738.60M$87.24M-15.19356Short Interest ↓News CoveragePositive NewsUSNAUSANA Health Sciences2.7963 of 5 stars$36.57-0.2%$35.00-4.3%-30.7%$697.02M$921.01M12.951,800MNMDMind Medicine (MindMed)2.1473 of 5 stars$7.39+3.2%$27.71+275.0%+123.3%$541.92MN/A-3.1757Analyst ForecastNews CoverageCDXCChromaDex4.6512 of 5 stars$6.10-0.3%$8.00+31.1%+334.8%$465.94M$91.67M620.00106Analyst DowngradeBTMDbiote3.4078 of 5 stars$6.59+3.5%$9.11+38.2%+24.5%$358.08M$193.06M24.77194Analyst ForecastNews CoveragePositive NewsGap UpCGCCanopy Growth2.4144 of 5 stars$3.07-1.3%$3.50+14.0%-41.2%$334.45M$220.27M-0.631,029Analyst DowngradeShort Interest ↓News CoverageACBAurora Cannabis0.3095 of 5 stars$4.30-0.2%N/A-6.9%$235.81M$200.35M-5.671,073MDWDMediWound1.8751 of 5 stars$17.36+0.4%$27.50+58.4%+64.0%$187.25M$19.72M-5.9380Positive NewsGap DownFTLFFitLife Brands3.219 of 5 stars$33.50-1.5%$40.00+19.4%+51.2%$154.03M$62.76M20.1220SNYRSynergy CHC Corp. (Uplisting)N/A$5.50+4.4%N/AN/A$47.85MN/A0.0040Positive NewsGap Up Related Companies and Tools Related Companies CRON Competitors USNA Competitors MNMD Competitors CDXC Competitors BTMD Competitors CGC Competitors ACB Competitors MDWD Competitors FTLF Competitors SNYR Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TLRY) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tilray Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Tilray With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TLRY Stock Alerts